Clinical Trials Directory

Trials / Completed

CompletedNCT00199563

Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels

The Use and Efficacy of Sildenafil in Diabetic Men With Erectile Dysfunction: the Impact on Endothelial Function, a Pilot Feasibility Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

* To evaluate the impact of nightly sildenafil vs placebo use on diabetic men with and without proven endothelial dysfunction and coexisting erectile concerns. * To determine if chronic sildenafil use compared to placebo positively impacts endothelial function among a cohort of diabetic mend with erectile dysfunction * To assess the salvage rate of sildenafil - failures who demonstrate improved response rates over time with chronic use * To assess if microalbuminuria predicts flow-mediated dilation (FMD) response * To measure and identify if other patient specific characteristics predict for sildenafil erectile response and flow-mediated dilatation (FMD) response over time (patient specifics; blood pressure, HBA1c, weight, BMI, age IIEF score at baseline)

Detailed description

60 type II diabetic men with erectile dysfunction will be enrolled in this trial, evaluated over a 12 week period. Randomization into one of two arms (placebo, daily sildenafil 50mg) will be a doubly blinded. Subjects will be followed by IIEF, diaries and brachial forearm medial dilatation duplex scans, urinary microalbuminuria and serum chemistry. Study time-points are at baseline, 6 and 12 weeks. Study participants will be instructed to use the study medication at the specified frequency but will be allowed flexibility to suit their erectile needs.

Conditions

Interventions

TypeNameDescription
DRUGViagraSildenafil 100mg daily for 12 weeks

Timeline

Start date
2004-08-01
Primary completion
2007-10-01
Completion
2007-12-01
First posted
2005-09-20
Last updated
2018-11-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00199563. Inclusion in this directory is not an endorsement.